Diagnosis and Immediate Management
This patient is experiencing an acute asthma exacerbation with features of moderate severity, likely triggered by an upper respiratory tract infection (viral pharyngitis), and requires immediate escalation of therapy with systemic corticosteroids and consideration for nebulized bronchodilators.
Most Likely Diagnosis
Acute moderate asthma exacerbation with concurrent viral upper respiratory tract infection (pharyngitis)
The clinical picture strongly suggests:
Asthma exacerbation triggered by viral upper respiratory infection, evidenced by the progression from dry to productive cough with yellow sputum, erythematous boggy tonsils, increased rescue inhaler use (escalating from baseline to 4 puffs out of maximum 8), and faint expiratory wheezes 1.
Severity assessment indicates moderate exacerbation based on: pulse rate 105 BPM (>110 is severe), increased rescue medication requirements, and persistent symptoms despite current therapy, though she can likely complete sentences (not documented as unable) 1.
Viral pharyngitis as the precipitating factor, supported by erythematous boggy tonsils without exudates, absence of fever, and the clinical timeline 1.
Immediate Management Steps
1. Severity Assessment and Objective Measurements
Obtain peak expiratory flow (PEF) measurement immediately to objectively assess severity, as clinical assessment alone often underestimates severity 1.
- PEF <50% predicted or personal best = severe exacerbation requiring aggressive treatment 1
- PEF 50-75% predicted or personal best = moderate exacerbation 1
- PEF >75% predicted or personal best = mild exacerbation 1
Reassess vital signs after patient rests, as the tachycardia (105 BPM) and elevated blood pressure (137/98) may be partially due to recent exertion from walking 1.
2. Immediate Pharmacologic Intervention
Administer systemic corticosteroids immediately:
- Prednisolone 30-60 mg orally OR hydrocortisone 200 mg intravenously 1
- This should be given regardless of PEF results given the 4-day duration, increased rescue use, and nocturnal symptoms 1
Nebulized bronchodilator therapy:
- Salbutamol 5 mg OR terbutaline 10 mg via nebulizer (oxygen-driven if available) 1
- If nebulizer unavailable: give 2 puffs of β-agonist via large volume spacer, repeat 10-20 times 1
Consider adding ipratropium bromide 0.5 mg to the nebulized β-agonist if response to initial treatment is inadequate after 15-30 minutes 1.
3. Monitoring Response (15-30 Minutes Post-Treatment)
Reassess PEF, vital signs, and clinical status 15-30 minutes after nebulizer treatment 1.
If PEF >50-75% predicted/best after treatment:
- Continue prednisolone 30-60 mg daily 1
- Step up maintenance therapy: increase Symbicort to 160/4.5 mcg, 2 inhalations twice daily (if not already at this dose) 2
- Arrange follow-up within 48 hours 1
If PEF remains <50% predicted/best OR any severe features persist:
- Arrange hospital admission 1
- Repeat nebulized β-agonist more frequently (up to every 15 minutes) 1
- Add nebulized ipratropium 0.5 mg 1
4. Criteria for Hospital Admission
Lower threshold for admission given this patient has multiple risk factors 1:
- Afternoon/evening presentation (higher risk time) 1
- Recent nocturnal symptoms and symptom worsening 1
- Increased rescue medication use (4 puffs, approaching maximum 8) 1
- History of coronary stenting (cardiovascular comorbidity) 1
Admit if any of the following:
- PEF <33% predicted/best after initial treatment 1
- Inability to complete sentences in one breath 1
- Respiratory rate >25/min 1
- Pulse >110 BPM (she is at 105, borderline) 1
- Inadequate response to initial treatment 1
5. Additional Investigations
Chest radiography if admitted or if clinical features suggest complications (to exclude pneumonia, pneumothorax, or pulmonary edema) 1.
Pulse oximetry to assess for hypoxemia (target oxygen saturation >92%) 1.
Consider complete blood count given productive yellow sputum, though antibiotics are indicated only if bacterial infection is confirmed 1. The absence of fever and presence of viral pharyngitis make bacterial pneumonia less likely 1.
Maintenance Therapy Adjustments
Step up inhaled corticosteroid therapy:
- If currently on Symbicort 160/4.5 mcg (1 inhalation twice daily), increase to 2 inhalations twice daily 1, 2
- Continue this higher dose for at least 2-4 weeks, then reassess 1
Continue levocetirizine/montelukast as prescribed, as leukotriene inhibitors provide additional benefit in asthma with incomplete response to ICS 1, 3.
Continue N-acetylcysteine for mucolytic effect given productive cough 3.
Critical Pitfalls to Avoid
- Do not underestimate severity based on clinical assessment alone—objective PEF measurement is essential 1
- Do not delay systemic corticosteroids—they should be given immediately, not after failed bronchodilator response 1
- Do not prescribe antibiotics unless bacterial infection is confirmed; they are not indicated for viral pharyngitis or asthma exacerbation alone 1
- Do not use sedatives—any sedation is contraindicated in acute asthma 1
- Do not exceed maximum Symbicort dosing (8 inhalations/day of 160/4.5 mcg strength) 2
- Reassess cardiovascular status given history of coronary stenting and current tachycardia, especially with β-agonist use 2
Follow-Up Plan
If treated as outpatient:
- Surgery review within 48 hours mandatory 1
- Monitor symptoms and PEF on chart daily 1
- Provide written self-management plan 1
- Verify inhaler technique 1
- Continue prednisolone for 5-7 days minimum 1
If admitted:
- Continue high-dose systemic steroids (prednisolone 30-60 mg daily or IV hydrocortisone 200 mg every 6 hours) 1
- Nebulized β-agonist every 4 hours if improving, or more frequently (every 15 minutes) if not 1
- Discharge only when PEF >75% predicted/best and patient stable on discharge medications for 24 hours 1